Advancing Infectious Keratitis Treatment with Slit-Lamp CXL
Corneal Physician reports on ELZA's exploration of slit-lamp CXL as a promising, accessible treatment for infectious…
CXL Explained
Corneal Physician reports on ELZA's exploration of slit-lamp CXL as a promising, accessible treatment for infectious…
Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving…
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
The AAO-ESCRS Joint Symposium, convened leading ophthalmology experts to explore the latest developments in CXL.
ELZA-PACE not only improves corneal biomechanics (just like regular CXL) but by flattening the cone significantly,…
Ophthalmologie Nachrichten recently featured an article from the ELZA Institute, highlighting advancements in corneal cross-linking (CXL).…
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements…
The Ophthalmologist's "CXL: What's New in 2023?" article explores advancements in corneal collagen crosslinking for treating…
Emilio Torres-Netto, MD, PhD spoke to Ocular Surgery News about the ELZA Institute’s latest data on the second-generation customized…
EMAGine’s Medical Director, Prof. Farhad Hafezi, and its CEO, Nikki Hafezi, presented remotely at the CXL…
Nikki Hafezi MAS IP ETHZ, the CEO of the ELZA Institute in Zurich, continues to drive innovation…
Switzerland, particularly Zurich, has been a leader in corneal cross-linking (CXL) research and innovation for over…
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can…
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently…
An article by Prof. Farhad Hafezi, MD, PhD, FARVO, Medical Director of the ELZA Institute, published…
The advantages of performing corneal cross-linking (CXL) at the slit lamp are well established. It brings…
It has been quite the debate. Should surgeons drop riboflavin onto the cornea during the UV…
Keratoconus and Down Syndrome: How effective is CXL at treating KC in Down Syndrome? This is…
Our latest review on "CXL in thin corneas". It describes all current approaches how to treat…
High fluence PACK-CXL has progressed a great deal since it was first developed (1) as a…
A literature analysis that showed that Farhad Hafezi is the world's top ranked author in CXL-…
EMAGine's Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared…
Today, a landmark PACK-CXL trial was published that shows that PACK-CXL is an effective corneal infection…
TouchOphthalmology interviewed Prof. Farhad Hafezi on why it’s taken until now to have an effective epi-on CXL…
PACK-CXL is safe for use in bacterial keratitis cases. It also seems to add value in…
It can be challenging to cross-link the eyes of wheelchair users – for the patient and…
Accelerated CXL - but without trading off strength? ELZA researchers have developed a protocol that's ~9…
Prof. Hafezi reviews the CXL at the Slit Lamp technique in US Ophthalmic Review
Nikki Hafezi's successful launch of slit lamp cross-linking technology.
It’s clear that there is a link between eye rubbing and keratoconus. Eye rubbing can alter the…
Nikki Hafezi's successful launch of slit lamp cross-linking technology.
Short introduction video to the C-eye device and Ribo-Ker riboflavin solution.
Models include SL-120 and SL-220
Laurence Derbyshire interviews Farhad Hafezi about C-eye
Roibeard O’hEineachain interviews Dr. Emilio Torres-Netto
Prof. Farhad Hafezi is interviewed by Optometry Today
PACK-CXL for infectious keratitis is not like treating keratoconus with CXL.
Dr. Emilio Torres interviews Prof. Farhad Hafezi
Oftalmologica Em Foco features Prof. Hafezi and Dr. Torres-Netto
